Fate Therapeutics Inc FATE:NASDAQ

Last Price$15.95NASDAQ Previous Close - Last Trade as of 4:00PM ET 3/25/19

Today's Change-0.19(1.18%)
Bid (Size)$15.60 (2)
Ask (Size)$19.15 (2)
Day Low / High$15.59 - 16.54
Volume527.9 K
ValuationIndustry Range
Price / Earnings N/A
0.26372.23
Book Value 1.84
 
-16.0280.34
Earnings Per Share -$1.20
 
-15.9421.60
Price To Sales Ratio 165.50
 
0.4214.7K
Price To Book Ratio 7.71
 
N/A95.7K
Price To Tangible Book Ratio 7.71
 
0.34177.19
Price/Cash Flow Ratio N/A
0.77746.08
Price/Free Cash Flow Ratio N/A
0.77153.35
ProfileIndustry Range
Market Capitalization 1.1B
 
3.2M112.6B
Float (MRQ)N/A
0.00131.73
Shares Outstanding (MRQ)64.7M
 
417.8 K1.3 B
Short Interest as a % of Float (MRQ)13.50%
 
N/AN/A
Shares Held By Institutions (MRQ)55.6M
 
0.00131.73
MarginsIndustry Range
Sales $4.7M
 
0.006.2B
Gross Margin N/A
-3.9K98.92
Net Profit Margin -1,405.02%
 
-500.9K176.68
EBIT Margin -1,415.44%
 
-563.7K65.11
EBITDA Margin -1,390.04%
 
-561.2K71.75
Operating Margins -1,415.44%
 
N/AN/A
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K statement or press releases. MRQ = Most Recent Quarter
Financial StrengthIndustry Range
Current Ratio (MRQ)7.53
 
0.0843.56
Quick Ratio (MRQ)7.53
 
0.0843.56
Total Debt/Equity Ratio (MRQ)9.28
 
0.001,460,694.54
Debt/Common Equity Ratio (MRQ)9.28
 
0.001,460,694.54
EffectivenessIndustry Range
Return on Equity -59.04%
 
-4.3K750.90
Return on Assets -43.70%
 
-3.1K672.51
Asset Turnover 0.03
 
0.002.91
Receivables Turnover 12.64
 
0.00306.00
Inventory Turnover N/A
0.28513.00
Earnings and DividendsIndustry Range
EPS Growth Annual 17.65%
 
N/AN/A
Dividend Yield 5 Year Average 0.00%
 
0.0092.21
Current Dividend Yield N/A
0.68 3.99
Current Payout Ratio N/A
0.0089.64
*FATE does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 3.13%